Factors Associated With Chlamydia and Gonorrhea Treatment Completion Among Sexual Health Clinic Patients, Baltimore City, Maryland; 2018 to 2019

Prompt and appropriate treatment of Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) is critical to prevent transmission and serious sequelae. The objectives were to determine the prevalence of CT/NG treatment completion and identify demographic, behavioral, and clinical factors associated...

Full description

Saved in:
Bibliographic Details
Published in:Sexually transmitted diseases Vol. 50; no. 5; p. 265
Main Authors: Stracker, Norberth, Williford, Sarah L, Gilliams, Elizabeth, Rives, Sarah, Page, Kathleen R, Hamill, Matthew M, Greenbaum, Adena, Schumacher, Christina M
Format: Journal Article
Language:English
Published: United States 01.05.2023
Subjects:
Baltimore - epidemiology
Chlamydia Infections - diagnosis
Chlamydia Infections - drug therapy
Chlamydia Infections - epidemiology
Chlamydia trachomatis
Female
Gonorrhea - diagnosis
Gonorrhea - drug therapy
Gonorrhea - epidemiology
Humans
Male
Neisseria gonorrhoeae
Prevalence
Sexual Health
Baltimore
ISSN:1537-4521, 1537-4521
Online Access:Get more information
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Prompt and appropriate treatment of Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) is critical to prevent transmission and serious sequelae. The objectives were to determine the prevalence of CT/NG treatment completion and identify demographic, behavioral, and clinical factors associated with treatment completion at sexual health clinics in Baltimore City, Maryland. Electronic health record data from patients diagnosed with CT/NG during 2018-2019 were analyzed. Treatment completion was defined as documentation of Centers for Disease Control and Prevention-recommended treatment ≤30 days after testing. Regression was used to assess differences in treatment completion across groups; analyses were stratified by birth sex. Most of the 2426 male (86%) and 754 (72%) female patients diagnosed with CT/NG completed treatment in ≤30 days; 74% of male and 36% of female patients were treated same-day. Among 890 male patients not treated same-day, treatment completion was associated with other same-day antimicrobial treatments (adjusted prevalence ratio, 0.76 [95% confidence interval, 0.61-0.94]), longer test processing times (≥10 days; 0.78 [0.65-0.95]) infection at multiple anatomic sites (1.49 [1.25-1.76]), and patients with previous clinic visits (1.16 [1.03-1.31]). Among 483 female patients not treated same-day, treatment completion was associated with diagnosis year (2019 vs. 2018; 1.23 [1.05-1.43]) and residential addresses 2 to 5 miles (vs. <2 miles) from clinic (1.25 [1.02-1.53]). Demographic and behavioral characteristics were not associated with treatment completion. Substantial proportions of male and female sexual health clinic patients did not complete treatment. Our findings underscore the need for implementation of highly sensitive and specific point-of-care (POC) CT/NG testing to improve treatment completion in this setting.
AbstractList Prompt and appropriate treatment of Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) is critical to prevent transmission and serious sequelae. The objectives were to determine the prevalence of CT/NG treatment completion and identify demographic, behavioral, and clinical factors associated with treatment completion at sexual health clinics in Baltimore City, Maryland.BACKGROUNDPrompt and appropriate treatment of Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) is critical to prevent transmission and serious sequelae. The objectives were to determine the prevalence of CT/NG treatment completion and identify demographic, behavioral, and clinical factors associated with treatment completion at sexual health clinics in Baltimore City, Maryland.Electronic health record data from patients diagnosed with CT/NG during 2018-2019 were analyzed. Treatment completion was defined as documentation of Centers for Disease Control and Prevention-recommended treatment ≤30 days after testing. Regression was used to assess differences in treatment completion across groups; analyses were stratified by birth sex.METHODSElectronic health record data from patients diagnosed with CT/NG during 2018-2019 were analyzed. Treatment completion was defined as documentation of Centers for Disease Control and Prevention-recommended treatment ≤30 days after testing. Regression was used to assess differences in treatment completion across groups; analyses were stratified by birth sex.Most of the 2426 male (86%) and 754 (72%) female patients diagnosed with CT/NG completed treatment in ≤30 days; 74% of male and 36% of female patients were treated same-day. Among 890 male patients not treated same-day, treatment completion was associated with other same-day antimicrobial treatments (adjusted prevalence ratio, 0.76 [95% confidence interval, 0.61-0.94]), longer test processing times (≥10 days; 0.78 [0.65-0.95]) infection at multiple anatomic sites (1.49 [1.25-1.76]), and patients with previous clinic visits (1.16 [1.03-1.31]). Among 483 female patients not treated same-day, treatment completion was associated with diagnosis year (2019 vs. 2018; 1.23 [1.05-1.43]) and residential addresses 2 to 5 miles (vs. <2 miles) from clinic (1.25 [1.02-1.53]). Demographic and behavioral characteristics were not associated with treatment completion.RESULTSMost of the 2426 male (86%) and 754 (72%) female patients diagnosed with CT/NG completed treatment in ≤30 days; 74% of male and 36% of female patients were treated same-day. Among 890 male patients not treated same-day, treatment completion was associated with other same-day antimicrobial treatments (adjusted prevalence ratio, 0.76 [95% confidence interval, 0.61-0.94]), longer test processing times (≥10 days; 0.78 [0.65-0.95]) infection at multiple anatomic sites (1.49 [1.25-1.76]), and patients with previous clinic visits (1.16 [1.03-1.31]). Among 483 female patients not treated same-day, treatment completion was associated with diagnosis year (2019 vs. 2018; 1.23 [1.05-1.43]) and residential addresses 2 to 5 miles (vs. <2 miles) from clinic (1.25 [1.02-1.53]). Demographic and behavioral characteristics were not associated with treatment completion.Substantial proportions of male and female sexual health clinic patients did not complete treatment. Our findings underscore the need for implementation of highly sensitive and specific point-of-care (POC) CT/NG testing to improve treatment completion in this setting.CONCLUSIONSSubstantial proportions of male and female sexual health clinic patients did not complete treatment. Our findings underscore the need for implementation of highly sensitive and specific point-of-care (POC) CT/NG testing to improve treatment completion in this setting.
Prompt and appropriate treatment of Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) is critical to prevent transmission and serious sequelae. The objectives were to determine the prevalence of CT/NG treatment completion and identify demographic, behavioral, and clinical factors associated with treatment completion at sexual health clinics in Baltimore City, Maryland. Electronic health record data from patients diagnosed with CT/NG during 2018-2019 were analyzed. Treatment completion was defined as documentation of Centers for Disease Control and Prevention-recommended treatment ≤30 days after testing. Regression was used to assess differences in treatment completion across groups; analyses were stratified by birth sex. Most of the 2426 male (86%) and 754 (72%) female patients diagnosed with CT/NG completed treatment in ≤30 days; 74% of male and 36% of female patients were treated same-day. Among 890 male patients not treated same-day, treatment completion was associated with other same-day antimicrobial treatments (adjusted prevalence ratio, 0.76 [95% confidence interval, 0.61-0.94]), longer test processing times (≥10 days; 0.78 [0.65-0.95]) infection at multiple anatomic sites (1.49 [1.25-1.76]), and patients with previous clinic visits (1.16 [1.03-1.31]). Among 483 female patients not treated same-day, treatment completion was associated with diagnosis year (2019 vs. 2018; 1.23 [1.05-1.43]) and residential addresses 2 to 5 miles (vs. <2 miles) from clinic (1.25 [1.02-1.53]). Demographic and behavioral characteristics were not associated with treatment completion. Substantial proportions of male and female sexual health clinic patients did not complete treatment. Our findings underscore the need for implementation of highly sensitive and specific point-of-care (POC) CT/NG testing to improve treatment completion in this setting.
Author Page, Kathleen R
Hamill, Matthew M
Gilliams, Elizabeth
Stracker, Norberth
Rives, Sarah
Williford, Sarah L
Schumacher, Christina M
Greenbaum, Adena
Author_xml – sequence: 1
  givenname: Norberth
  surname: Stracker
  fullname: Stracker, Norberth
– sequence: 2
  givenname: Sarah L
  surname: Williford
  fullname: Williford, Sarah L
– sequence: 3
  givenname: Elizabeth
  surname: Gilliams
  fullname: Gilliams, Elizabeth
– sequence: 4
  givenname: Sarah
  surname: Rives
  fullname: Rives, Sarah
– sequence: 5
  givenname: Kathleen R
  surname: Page
  fullname: Page, Kathleen R
  organization: Division of Infectious Diseases
– sequence: 6
  givenname: Matthew M
  surname: Hamill
  fullname: Hamill, Matthew M
– sequence: 7
  givenname: Adena
  surname: Greenbaum
  fullname: Greenbaum, Adena
  organization: From the Baltimore City Health Department
– sequence: 8
  givenname: Christina M
  surname: Schumacher
  fullname: Schumacher, Christina M
  organization: Center for Child and Community Health Research, Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD
BackLink https://www.ncbi.nlm.nih.gov/pubmed/36728272$$D View this record in MEDLINE/PubMed
BookMark eNpNkF9LwzAUxYNM3B_9BiJ59GGbSdo0CT7N4jZhMsWJjyOmty7SNrNJwX0LP7IdTth9OZfLj8M5t486lasAoUtKxpQocbNcPI_J0VAhyAnqUR6JUcwZ7RztXdT3_rNlYknoGepGiWCSCdZDP1Ntgqs9nnjvjNUBMvxmwwanm0KXu8xqrKsMz1zl6noDGq9q0KGEKuDUldsCgnUVnpSu-sAv8N3oAs9BF3uDwlbW4CcdbEv7Ib5rz7Z0NeDUht0QP-p6V7Tmt5gRKnFwe1Xn6DTXhYeLgw7Q6_R-lc5Hi-XsIZ0sRiaSJB7lOZE5J0wRIpSJE9NWSnJFScypBCKJyWgMECUqkozrnHOQXOUkEYoZFjM2QNd_vtvafTXgw7q03kDRJgLX-DUTgqpIEc5b9OqANu8lZOttbcs2-_r_i-wXyzZ0mQ
CitedBy_id crossref_primary_10_1097_OLQ_0000000000002098
crossref_primary_10_1177_20499361241265941
ContentType Journal Article
Copyright Copyright © 2023 American Sexually Transmitted Diseases Association. All rights reserved.
Copyright_xml – notice: Copyright © 2023 American Sexually Transmitted Diseases Association. All rights reserved.
DBID CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1097/OLQ.0000000000001770
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Medicine
EISSN 1537-4521
ExternalDocumentID 36728272
Genre Research Support, U.S. Gov't, P.H.S
Journal Article
GeographicLocations Baltimore
GeographicLocations_xml – name: Baltimore
GroupedDBID ---
-ET
..I
.XZ
.Z2
01R
0R~
123
1J1
354
40H
4Q1
4Q2
4Q3
5RE
5VS
71W
77Y
7O~
AAAAV
AAAXR
AAGIX
AAHPQ
AAIQE
AAJCS
AAMOA
AAMTA
AAQKA
AARTV
AASCR
AASOK
AASXQ
AAUEB
AAWTL
AAXQO
AAYEP
ABASU
ABBUW
ABDIG
ABHFT
ABJNI
ABVCZ
ABXVJ
ABZAD
ACDDN
ACEWG
ACGFO
ACGFS
ACIJW
ACILI
ACLDA
ACOAL
ACPRK
ACWDW
ACWRI
ACXJB
ACXNZ
ADGGA
ADHPY
AE6
AEBDS
AENEX
AFDTB
AFEXH
AFRAH
AFSOK
AFUWQ
AGINI
AHMBA
AHOMT
AHQNM
AHVBC
AIJEX
AINUH
AJCLO
AJIOK
AJNWD
AJZMW
AKCTQ
AKULP
ALKUP
ALMA_UNASSIGNED_HOLDINGS
ALMTX
AMJPA
AMKUR
AMNEI
AOHHW
ASUFR
AWKKM
BKOMP
BOYCO
BQLVK
BYPQX
C45
CGR
CS3
CUY
CVF
DIWNM
DU5
E.X
EBS
ECM
EEVPB
EIF
ERAAH
EX3
F2M
F2N
F5P
FCALG
FL-
FRP
GNXGY
GQDEL
H0~
HLJTE
HZ~
IKREB
IKYAY
IN~
IPNFZ
JK3
JK8
K8S
KD2
L-C
L7B
LMP
NPM
N~7
N~B
O9-
OAG
OAH
OBH
ODA
ODMTH
OHH
OHYEH
OK1
OLB
OLG
OLH
OLU
OLW
OLY
OPUJH
OVD
OVDNE
OVIDH
OVLEI
OVOZU
OWV
OWW
OWZ
OXXIT
P2P
PQQKQ
RIG
RLZ
RXW
S4R
S4S
TAE
TEORI
TR2
TSPGW
V2I
VVN
W2D
W3M
WH7
WOQ
WOW
X3V
X3W
XFW
XYM
YFH
YOC
ZFV
ZY1
7X8
ABPXF
ABXYN
ABZZY
ACBKD
ACDOF
ACZKN
ADKSD
ADSXY
AFBFQ
AFMBP
AFNMH
AHQVU
AOQMC
ID FETCH-LOGICAL-c3804-ff08f50290079c46c3676f9104518e080cd14ee3693825af55e859f06792c2422
IEDL.DBID 7X8
ISICitedReferencesCount 3
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=00007435-202305000-00004&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1537-4521
IngestDate Sun Nov 09 10:35:05 EST 2025
Wed Feb 19 02:24:53 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 5
Language English
License Copyright © 2023 American Sexually Transmitted Diseases Association. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3804-ff08f50290079c46c3676f9104518e080cd14ee3693825af55e859f06792c2422
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 36728272
PQID 2771939055
PQPubID 23479
ParticipantIDs proquest_miscellaneous_2771939055
pubmed_primary_36728272
PublicationCentury 2000
PublicationDate 2023-05-01
20230501
PublicationDateYYYYMMDD 2023-05-01
PublicationDate_xml – month: 05
  year: 2023
  text: 2023-05-01
  day: 01
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Sexually transmitted diseases
PublicationTitleAlternate Sex Transm Dis
PublicationYear 2023
SSID ssj0014801
Score 2.3967278
Snippet Prompt and appropriate treatment of Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) is critical to prevent transmission and serious sequelae. The...
SourceID proquest
pubmed
SourceType Aggregation Database
Index Database
StartPage 265
SubjectTerms Baltimore - epidemiology
Chlamydia Infections - diagnosis
Chlamydia Infections - drug therapy
Chlamydia Infections - epidemiology
Chlamydia trachomatis
Female
Gonorrhea - diagnosis
Gonorrhea - drug therapy
Gonorrhea - epidemiology
Humans
Male
Neisseria gonorrhoeae
Prevalence
Sexual Health
Title Factors Associated With Chlamydia and Gonorrhea Treatment Completion Among Sexual Health Clinic Patients, Baltimore City, Maryland; 2018 to 2019
URI https://www.ncbi.nlm.nih.gov/pubmed/36728272
https://www.proquest.com/docview/2771939055
Volume 50
WOSCitedRecordID wos00007435-202305000-00004&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LS8NAEF58IV58P-qLETw2mPdm8SC1WD20tWLV3kqS3aW9JLWtQv-FP9mZbIInQTCHBBYCw-6Xybczs98wdun4Stna5VYY2Z7l-0lkJWiwhWTASYStPV6o87-2ebcbDQaiVwbcZmVZZeUTC0ct85Ri5Fcu58g1hB0EN5N3i7pGUXa1bKGxzFY9pDKEaj74ySKQNIrRSyVtb9epjs4JfvXYfjLSheXlcG7_TjKLn01r679mbrPNkmZCw-Bihy2pbJetd8pE-h77apk-O1Atj5LwNp6PoDlCiCwQNBBnEu7zLJ9O0V9DvypIB_IgpNidZ9CgTkXwXKg2gznQBEZoFHpGr3VWh1scHlM5LzSR8dehE08XVE55DcgKIpjn9BT77KV1128-WGVzBiv1Itu3tLYjHdiuQJIhUj9MSfpNI_nwAydSyENTSTjwQuHhJjTWQaCiQGiKW7kp8gL3gK1keaaOGGhXSpLVV4qUZ0SchNILVRJqL5aJDHiNXVRzPUTwU0YjzlT-MRv-zHaNHZoFG06MSscQ7cHtJHeP__D2CdugNvKmkPGUrWr89NUZW0s_5-PZ9LxAFd67vc435yHUAA
linkProvider ProQuest
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Factors+Associated+With+Chlamydia+and+Gonorrhea+Treatment+Completion+Among+Sexual+Health+Clinic+Patients%2C+Baltimore+City%2C+Maryland%3B+2018+to+2019&rft.jtitle=Sexually+transmitted+diseases&rft.au=Stracker%2C+Norberth&rft.au=Williford%2C+Sarah+L&rft.au=Gilliams%2C+Elizabeth&rft.au=Rives%2C+Sarah&rft.date=2023-05-01&rft.eissn=1537-4521&rft.volume=50&rft.issue=5&rft.spage=265&rft_id=info:doi/10.1097%2FOLQ.0000000000001770&rft_id=info%3Apmid%2F36728272&rft_id=info%3Apmid%2F36728272&rft.externalDocID=36728272
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1537-4521&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1537-4521&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1537-4521&client=summon